Literature DB >> 2041953

Infections with Chryseomonas luteola (CDC group Ve-1) and Flavimonas oryzihabitans (CDC group Ve-2) in neurosurgical patients.

J R Kostman1, F Solomon, T Fekete.   

Abstract

During a 20-month period at Temple University Hospital, three cases of infection with bacteria of the Ve group--Chryseomonas luteola (CDC group Ve-1) and Flavimonas oryzihabitans (CDC group Ve-2)--were seen in neurosurgical patients. Two of the patients, including one with what is thought to be the first reported case of meningitis due to C. luteola, had complications caused by prosthetic material. A review of the literature revealed 14 well-described cases of infection with C. luteola or F. oryzihabitans, the majority of which were cases of bacteremia or peritonitis in patients undergoing dialysis. The presence of foreign material and the use of corticosteroids may predispose to and influence the course of disease. As prosthetic material becomes even more widely used, the incidence of infection with bacteria of the Ve group will likely increase and the manifestations of the infections will probably become more varied.

Entities:  

Mesh:

Year:  1991        PMID: 2041953     DOI: 10.1093/clinids/13.2.233

Source DB:  PubMed          Journal:  Rev Infect Dis        ISSN: 0162-0886


  14 in total

1.  A rare cause of peritonitis caused by Flavimonas oryzihabitans in continuous ambulatory peritoneal dialysis (CAPD).

Authors:  Stamatina Papakonstantinou; Evangelia Dounousi; Kyriakos Ioannou; Ioannis Tsouchnikas; Apostolos Kelesidis; Nikolaos Kotzadamis; Dimitrios Tsakiris
Journal:  Int Urol Nephrol       Date:  2005       Impact factor: 2.370

2.  Unusual clinical presentation of infection due to Flavimonas oryzihabitans.

Authors:  A Giacometti; O Cirioni; M Quarta; A M Schimizzi; M S Del Prete; G Scalise
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1998-09       Impact factor: 3.267

3.  Molecular and biochemical characterization of the natural chromosome-encoded class A beta-lactamase from Pseudomonas luteola.

Authors:  Benoît Doublet; Frédéric Robin; Isabelle Casin; Laëtitia Fabre; Anne Le Fleche; Richard Bonnet; François-Xavier Weill
Journal:  Antimicrob Agents Chemother       Date:  2009-11-02       Impact factor: 5.191

4.  Haemorrhagic papular rash associated to Flavimonas oryzihabitans bacteraemia in a child.

Authors:  A Kansouzidou; C Charitidou; E Poubrou; V D Daniilidis; H Tsagaropoulou
Journal:  Eur J Epidemiol       Date:  2000-03       Impact factor: 8.082

Review 5.  Infections due to Flavimonas oryzihabitans: case report and literature review.

Authors:  J Esteban; M L Valero-Moratalla; R Alcazar; F Soriano
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1993-10       Impact factor: 3.267

6.  Epidemiological typing of Flavimonas oryzihabitans by PCR and pulsed-field gel electrophoresis.

Authors:  P Y Liu; Z Y Shi; Y J Lau; B S Hu; J M Shyr; W S Tsai; Y H Lin; C Y Tseng
Journal:  J Clin Microbiol       Date:  1996-01       Impact factor: 5.948

7.  Chryseomonas luteola bloodstream infection in a pediatric patient with pulmonary arterial hypertension receiving intravenous treprostinil therapy.

Authors:  A Y Wen; I K Weiss; R B Kelly
Journal:  Infection       Date:  2013-01-18       Impact factor: 3.553

8.  Chryseomonas luteola identified as the source of serious infections in a Moroccan University Hospital.

Authors:  Wafae Chihab; Ahmed S Alaoui; Mohamed Amar
Journal:  J Clin Microbiol       Date:  2004-04       Impact factor: 5.948

9.  In vitro activities of antimicrobial agents against clinical isolates of Flavimonas oryzihabitans obtained from patients with cancer.

Authors:  K V Rolston; D H Ho; B LeBlanc; G P Bodey
Journal:  Antimicrob Agents Chemother       Date:  1993-11       Impact factor: 5.191

10.  Empyema Caused by Pseudomonas luteola: A Case Report.

Authors:  Farid Yousefi; Saeed Shoja; Negin Honarvar
Journal:  Jundishapur J Microbiol       Date:  2014-07-01       Impact factor: 0.747

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.